This photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md. U.S. regulators have approved a new type of coronavirus test that administration officials have touted as a key to opening up the country. The Food and Drug Administration on Saturday, May 9, 2020, announced emergency authorization for antigen tests developed by Quidel Corp. of San Diego. The test can rapidly detect fragments of virus proteins in samples collected from swabs inside the nasal cavity, the FDA said in a statement. (AP Photo/Jacquelyn Martin, File)

This photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md. U.S. regulators have approved a new type of coronavirus test that administration officials have touted as a key to opening up the country. The Food and Drug Administration on Saturday, May 9, 2020, announced emergency authorization for antigen tests developed by Quidel Corp. of San Diego. The test can rapidly detect fragments of virus proteins in samples collected from swabs inside the nasal cavity, the FDA said in a statement. (AP Photo/Jacquelyn Martin, File)

New coronavirus antigen test with fast results approved

U.S. regulators have approved a new type of coronavirus test.

By TOM KRISHER

Associated Press

U.S. regulators have approved a new type of coronavirus test that administration officials have promoted as a key to opening up the country.

The Food and Drug Administration on Saturday announced emergency authorization for antigen tests developed by Quidel Corp. of San Diego. The test can rapidly detect fragments of virus proteins in samples collected from swabs swiped inside the nasal cavity, the FDA said in a statement.

The antigen test is the third type of test to be authorized by the FDA.

Currently, the only way to diagnose active COVID-19 is to test a patient’s nasal swab for the genetic material of the virus. While considered highly accurate, the tests can take hours and require expensive, specialized equipment mainly found at commercial labs, hospitals or universities.

A second type looks in the blood for antibodies, the proteins produced by the body days or weeks after fighting an infection. Such tests are helpful for researchers to understand how far a disease has spread within a community, but they aren’t useful for diagnosing active infections.

Antigen tests can diagnose active infections by detecting the earliest toxic traces of the virus rather than genetic code of the virus itself.

The FDA said that it expects to authorize more antigen tests in the future.

Quidel said Saturday that the test can provide an accurate, automated result in 15 minutes. The FDA’s emergency authorization “allows us to arm our health care workers and first responders with a frontline solution for COVID-19 diagnosis, accelerating the time to diagnosis and potential treatment,” Douglas Bryant, CEO of Quidel, said in a statement.

A genetic material test by Abbott Laboratories used at the White House also takes about 15 minutes.

The company said it specializes in testing for diseases and conditions including the flu and Lyme disease.

Quidel stock has more than doubled in value since the beginning of the year, closing Friday at $158.60.

The U.S. has tried to ramp up testing using the genetic method, but the country’s daily testing tally has been stuck in the 200,000 to 250,000-per-day range for several weeks, falling far short of the millions of daily tests that most experts say are needed to reopen schools, businesses, churches and other institutions of daily life.

That’s led White House adviser Dr. Deborah Birx and other federal officials to call for a “breakthrough” in the antigen tests.

“There will never be the ability on a nucleic acid test to do 300 million tests a day or to test everybody before they go to work or to school, but there might be with the antigen test,” Birx told reporters last month.

Recently, the National Institutes of Health announced $1.5 billion in research grants aimed at fast-tracking the development of rapid, easy-to-use testing approaches — including antigen tests — by the fall.

• This is an Associated Press report.

More in News

Jasmine Chavez, a crew member aboard the Quantum of the Seas cruise ship, waves to her family during a cell phone conversation after disembarking from the ship at Marine Park on May 10. (Mark Sabbatini / Juneau Empire file photo)
Ships in port for the week of June 15

Here’s what to expect this week.

(Michael Penn / Juneau Empire file photo)
Police calls for Thursday, June 13, 2024

This report contains public information from law enforcement and public safety agencies.

Bill Thomas, a former Republican state representative from Haines, announced Friday he is dropping out of the race for the District 3 House seat this fall. (U.S. Sustainability Alliance photo)
Bill Thomas drops out of District 3 House race, says there isn’t time for fishing and campaigning

Haines Republican cites rough start to commercial season; incumbent Andi Story now unopposed.

U.S. Rep. Mary Peltola, D-Alaska, speaks at the Alaska Democratic Party’s state convention on May 18 at Elizabeth Peratrovich Hall. (Mark Sabbatini / Juneau Empire file photo)
Peltola among few Democrats to vote for annual defense bill loaded with GOP ‘culture war’ amendments

Alaska congresswoman expresses confidence “poison pills” will be removed from final legislation.

A celebratory sign stands outside Goldbelt Inc.’s new building during the Alaska Native Regional Corporation’s 50th-anniversary celebration on Jan. 4. (Mark Sabbatini / Juneau Empire file photo)
Medical company sues Goldbelt for at least $30M in contract dispute involving COVID-19 vaccine needles

Company says it was stuck with massive stock of useless needles due to improper specs from Goldbelt.

(Michael Penn / Juneau Empire file photo)
Police calls for Wednesday, June 12, 2024

This report contains public information from law enforcement and public safety agencies.

A yearling black bear waits for its mother to return. Most likely she won’t. This time of year juvenile bears are separated, sometimes forcibly, by their mothers as families break up during mating season. (Photo courtesy K. McGuire)
Bearing witness: Young bears get the boot from mom

With mating season for adults underway, juveniles seek out easy food sources in neighborhoods.

A chart shows COVID-19 pathogen levels at the Mendenhall wastewater treatment plant during the past three months. (Data from the U.S. Centers for Disease Control and Prevention’s National Wastewater Surveillance System)
Juneau seeing another increase in COVID-19 cases, but a scarcity of self-test kits

SEARHC, Juneau Drug have limited kits; other locations expect more by Saturday.

Gov. Mike Dunleavy speaks to reporters during a news conference Feb. 7. (James Brooks/Alaska Beacon)
Gov. Dunleavy picks second ex-talk radio host for lucrative fish job after first rejected

Rick Green will serve at least through Legislature’s next confirmation votes in the spring of 2025.

Most Read